As part of our vision to transform patients’ lives through science, we are committed to addressing the needs of people living with neurological and neuropsychiatric conditions – pursuing bold science while always keeping patients at the center. Hear from Dr. Ken Kramer, PhD as our team prepares to attend the upcoming NEI Fall Congress, and learn more about our work in neuroscience: https://bit.ly/3X6bO6O #OneBMS
Excited to see you there!! Thanks Ken!
Good to see you, Ken!
Translating complexity into meaningful care remains the core challenge in neuropsychiatric drug development. BMS’s emphasis on patient-centered neuroscience is notable, not just identifying targets, but shaping interventions to account for real-world variability in cognition, mood, and function. Looking forward to seeing how this approach is evolving across programs and platforms.
Medical Learning Lead Neuropsychiatry @ BMS | PhD Microbiome-Gut Brain Axis
3dThat’s a booth I’d stop by! #OneBMS